Kolon Life Science Inc Sustainability Reports

The company develops cell and gene therapies, and manufactures active pharmaceutical ingredients (APIs), functional chemicals, and water treatment solutions.

Sector: Manufacturing

Country: South Korea

Exchange: Korea Exchange (KOSDAQ)

FIGI: BBG001SZY136

3 reports from 2024 to 2025

• Kolon Life Science Inc 2025 Sustainability Report
• Kolon Life Science Inc 2024 Sustainability Report
• Kolon Life Science Inc 2024 Sustainability Report 2024